A New Chemical Entity (NCE) in clinical trials represents a promising and innovative compound that holds potential therapeutic benefits for treating various medical conditions. The journey of an NCE begins with extensive research and preclinical development, where scientists assess its safety and efficacy in laboratory settings and animal models. Upon successful preclinical evaluations, the NCE progresses to clinical trials, a series of rigorous phases involving human subjects. These trials, typically divided into Phase I, II, and III, aim to systematically investigate the NCE’s safety profile, optimal dosage, and effectiveness in diverse patient populations. We have extensive Knowledge and Experience in NCE Clinical Development and provide the following services for NCE Clinical Trials.